Donep-M Tablet

Donep-M Tablet is a prescription combination tablet that contains donepezil and memantine in the strength shown on the pack label, with one tablet providing the exact labeled amount of each medicine. It belongs to the Alzheimer’s disease medicines class and is used to help manage symptoms of mild to severe dementia related to Alzheimer’s disease. Donep-M Tablet is not a cure, but it may help with memory, thinking, and daily function in some patients. Because it combines two medicines in one tablet, it is typically chosen when a doctor wants treatment that addresses Alzheimer’s symptoms from two different angles.

How it works: Donepezil helps the brain keep more of a chemical called acetylcholine, which can support memory and learning. Memantine works by helping regulate another brain chemical, glutamate, so brain cells are less overstimulated; together in Donep-M Tablet, they may help slow worsening of some Alzheimer’s symptoms.

Donep-M Tablet is a standard oral tablet form, so it is meant for people who can swallow tablets and whose doctor has decided this combined donepezil-plus-memantine strength is appropriate. Compared with lower-strength or single-ingredient options, this tablet is usually used when a clinician wants both medicines in one regimen rather than starting with only one drug. The exact labeled strength matters because donepezil and memantine can affect side effects and dose adjustments, especially in older adults or people with kidney, heart, or stomach problems.

• Treatment of Alzheimer’s disease dementia
• Help with memory and thinking problems
• Support for daily functioning in dementia
• Prescribed when a doctor wants combined donepezil and memantine therapy

• Swallow the Donep-M Tablet whole with water unless your doctor tells you otherwise.
• Take it exactly as prescribed; do not change the dose on your own.
• You may take it with or without food unless your prescriber gives different instructions.
• Take it at the same time each day to help you remember doses.
• Do not crush, split, or chew the tablet unless a pharmacist or doctor specifically says it is safe to do so.
• If a dose is missed, do not double up unless your doctor instructs you to do that.

Each Donep-M Tablet provides the labeled amount of donepezil plus the labeled amount of memantine in one tablet. Depending on the prescription, it may be taken once daily, but the exact schedule and any dose changes must be set by the doctor based on the patient’s response and kidney function. Do not take more than the prescribed number of tablets per day.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Donepezil + Memantine may include:

• Nausea
• Diarrhea
• Dizziness
• Headache
• Loss of appetite
• Constipation
• Sleep problems or unusual dreams

• Donep-M Tablet can cause dizziness or drowsiness, so use caution with driving or activities that need alertness.
• People with heart rhythm problems, slow pulse, or a history of fainting need close medical supervision.
• Tell the doctor if you have kidney disease, because memantine may need dose adjustment in some patients.
• Use caution if you have stomach ulcers or a history of gastrointestinal bleeding.
• Alcohol can worsen dizziness, confusion, or stomach upset.
• Do not stop the medicine suddenly unless the prescriber tells you to.
• Older adults may be more sensitive to side effects, especially at a higher labeled strength or when other medicines are also used.

• Anticholinergic medicines may reduce the benefit of donepezil.
• Other memantine-containing products can increase the risk of too much memantine.
• Drugs that slow the heart, including some beta-blockers, can increase the chance of low heart rate.
• NSAIDs, aspirin, warfarin, or other blood thinners may increase bleeding risk when combined with donepezil in some patients.
• Urine alkalinizing medicines or products may raise memantine levels.

Store Donep-M Tablet in the original strip or box at room temperature, away from moisture and direct light, and keep it out of reach of children.